Anna D. LoBue, Ph.D.
Affiliations: | 2008 | Microbiology & Immunology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Microbiology Biology, ImmunologyGoogle:
"Anna LoBue"Parents
Sign in to add mentor| Ralph S. Baric | grad student | 2008 | UNC Chapel Hill | |
| (Norovirus immunobiology and vaccine design.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| LoBue AD, Lindesmith LC, Baric RS. (2010) Identification of cross-reactive norovirus CD4+ T cell epitopes. Journal of Virology. 84: 8530-8 |
| Donaldson EF, Lindesmith LC, Lobue AD, et al. (2010) Viral shape-shifting: norovirus evasion of the human immune system. Nature Reviews. Microbiology. 8: 231-41 |
| LoBue AD, Thompson JM, Lindesmith L, et al. (2009) Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. Journal of Virology. 83: 3212-27 |
| Chachu KA, LoBue AD, Strong DW, et al. (2008) Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. Plos Pathogens. 4: e1000236 |
| Donaldson EF, Lindesmith LC, Lobue AD, et al. (2008) Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunological Reviews. 225: 190-211 |
| Chachu KA, Strong DW, LoBue AD, et al. (2008) Antibody is critical for the clearance of murine norovirus infection. Journal of Virology. 82: 6610-7 |
| Lindesmith LC, Donaldson EF, Lobue AD, et al. (2008) Mechanisms of GII.4 norovirus persistence in human populations. Plos Medicine. 5: e31 |
| Lindesmith LC, Donaldson EF, LoBue AD, et al. (2008) Phylogenic Reconstruction of the GII.4 Shell Domain and P1 and P2 Subdomains Plos Medicine |
| LoBue AD, Lindesmith L, Yount B, et al. (2006) Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine. 24: 5220-34 |